Aditi P. Singh, MD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Make an appointmentCall 215-615-5858
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Hematology-Oncology)

Education and training

  • Medical School: Lady Hardinge Medical College
  • Residency: University of Alabama at Birmingham (UAB Hospital)
  • Residency: Tufts - New England Medical Center
  • Fellowship: Montefiore Medical Center

What my patients think about me

Average Rating

303 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

October 2025
dr. singh has been very positive and proactive in support since our initial meeting 3 years ago when my diagnosis was not optimistic.
October 2025
explained well, answered all my questions,
October 2025
very competent
September 2025
because i'm very happy with the way she was talking about my situation thank you

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Singh is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Aditi P Singh, Abigail T Berman, Melina E Marmarelis, Andrew R Haas, Steven J Feigenberg, Jennifer Braun, Christine A Ciunci, Joshua M Bauml, Roger B Cohen, John C Kucharczuk, Lawrence N Shulman, Corey J Langer, Charu Aggarwal Management of Lung Cancer During the COVID-19 Pandemic , JCO Oncol Pract, 16(9): 2020,579-586

Charu Aggarwal, Jeffrey C. Thompson, Austin L. Chien, Katie J. Quinn, Wei-Ting Hwang, Taylor A. Black, Stephanie S. Yee, Theresa E. Christensen, Michael J. LaRiviere, Benjamin A. Silva, Kimberly C. Banks, Rebecca J. Nagy, Elena Helman, Abigail T. Berman, Christine A. Ciunci, Aditi P. Singh, Jeffrey S. Wasser, Joshua M. Bauml, Corey J. Langer, Roger B. Cohen and Erica L. Carpenter Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer , Clin Cancer Res , 26(10): 2020,2354-2361

Aditi P. Singh, Elaine Shum, Lakshmi Rajdev, Haiying Cheng, Sanjay Goel, Roman Perez-Soler, Balazs Halmos Impact and diagnostic gaps of comprehensive genomic profiling in real-world clinical practice , Cancers, 12(5): 2020,1156

Qinfang Deng, Qiyu Fang, Hui Sun Aditi P. Singh, Mariam Alexander, Shenduo Li, Haiying Cheng, Songwen Zhou. Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis , Cancer Med, 9(6): 2020,2085-2095

Attarian S, Guo X, Ko B, Singh AP, Castellucci E, Gucalp R, Haigentz M, Cheng H, Halmos B. Lung cancer in patients with HIV - Unique features impacting lung cancer screening and management , World Lung Cancer Conference - Virtual Meeting: 2019

Singh AP, Alexander M, Goradia N, Cheng H Practical Advice for Treating Leptomeningeal Disease in Non–Small Cell Lung Cancer , The Journal of Targeted Therapies in Cancer, 26(9): 2018

Singh AP, Cheng H, Guo X, Levy B, Halmos B. Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician , Journal of Clinical Oncology/Precision Oncology : 2017

Singh AP, Li S, Cheng H. Circulating DNA in EGFR-mutated lung cancer. , Ann Transl Med, 5(18): 2017,379

Hardin C, Shum E, Singh AP, Perez-Soler R, Cheng H. Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer. , Expert Opin Pharmacother, 18(7): 2017,701-716

Puri Singh A, Haywood C Jr, Beach MC, Guidera M, Lanzkron S, Valenzuela-Araujo D, Rothman RE, Dugas AF. Improving Emergency Providers' Attitudes Toward Sickle Cell Patients in Pain. , J Pain Symptom Manage, 51(3): 2016,628-32